Curadev India

Bayer AG has hit the acquisition trail again, having just agreed to buy the UK's KaNDy Therapeutics Ltd. , and a number of other deals are in the pipeline following a revamp of its partnering activi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Hoth, Voltron Form JV To Dev

German drug maker Bayer AG has entered a research and licensing agreement with privately held Curadev Pharma Pvt. Ltd. of India to explore and develop so-called stimulation of interferon genes (ST

Recent months have been marked by high-profile setbacks for a number of promising molecules being developed by companies in the Asia region, involving either the return of rights by licensees to origi